vs
Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $162.5M, roughly 1.8× Bitcoin Depot Inc.). Bio-Techne runs the higher net margin — 12.8% vs 3.4%, a 9.4% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -4.9%).
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
BTM vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $162.5M | $295.9M |
| Net Profit | $5.5M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 7.3% | 18.4% |
| Net Margin | 3.4% | 12.8% |
| Revenue YoY | 20.1% | -6.4% |
| Net Profit YoY | 690.4% | 68.3% |
| EPS (diluted) | $0.08 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $162.5M | — | ||
| Q2 25 | $172.1M | $317.0M | ||
| Q1 25 | $164.2M | $316.2M | ||
| Q4 24 | — | $297.0M | ||
| Q3 24 | $135.3M | $289.5M | ||
| Q2 24 | $163.1M | $306.1M | ||
| Q1 24 | $138.5M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $5.5M | — | ||
| Q2 25 | $6.1M | $-17.7M | ||
| Q1 25 | $4.2M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-939.0K | $33.6M | ||
| Q2 24 | $-2.6M | $40.6M | ||
| Q1 24 | $-1.5M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 7.3% | — | ||
| Q2 25 | 9.2% | -7.5% | ||
| Q1 25 | 10.8% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | 4.1% | 13.8% | ||
| Q2 24 | 4.7% | 15.0% | ||
| Q1 24 | 0.5% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.5% | -5.6% | ||
| Q1 25 | 2.6% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | -0.7% | 11.6% | ||
| Q2 24 | -1.6% | 13.3% | ||
| Q1 24 | -1.1% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.08 | — | ||
| Q2 25 | $0.16 | $-0.11 | ||
| Q1 25 | $0.20 | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-0.05 | $0.21 | ||
| Q2 24 | $-0.13 | $0.26 | ||
| Q1 24 | $-0.25 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $172.9M |
| Total DebtLower is stronger | $67.5M | $260.0M |
| Stockholders' EquityBook value | $21.0M | $2.0B |
| Total Assets | $125.3M | $2.5B |
| Debt / EquityLower = less leverage | 3.21× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $59.3M | — | ||
| Q2 25 | $48.0M | $162.2M | ||
| Q1 25 | $35.0M | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | $32.2M | $187.5M | ||
| Q2 24 | $43.9M | $152.9M | ||
| Q1 24 | $42.2M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $67.5M | — | ||
| Q2 25 | $66.5M | $346.0M | ||
| Q1 25 | $56.2M | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | $44.5M | $300.0M | ||
| Q2 24 | $41.2M | $319.0M | ||
| Q1 24 | $37.6M | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $21.0M | — | ||
| Q2 25 | $4.7M | $1.9B | ||
| Q1 25 | $-4.6M | $2.0B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $-7.9M | $2.1B | ||
| Q2 24 | $4.4M | $2.1B | ||
| Q1 24 | $5.0M | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $125.3M | — | ||
| Q2 25 | $109.1M | $2.6B | ||
| Q1 25 | $89.7M | $2.6B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $87.4M | $2.7B | ||
| Q2 24 | $97.5M | $2.7B | ||
| Q1 24 | $90.1M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 3.21× | — | ||
| Q2 25 | 14.18× | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | 9.27× | 0.15× | ||
| Q1 24 | 7.54× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | — |
| Free Cash FlowOCF − Capex | $2.5M | — |
| FCF MarginFCF / Revenue | 1.6% | — |
| Capex IntensityCapex / Revenue | 2.5% | — |
| Cash ConversionOCF / Net Profit | 1.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | $27.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $6.6M | — | ||
| Q2 25 | $10.2M | $98.2M | ||
| Q1 25 | $16.3M | $41.1M | ||
| Q4 24 | — | $84.3M | ||
| Q3 24 | $5.8M | $63.9M | ||
| Q2 24 | $10.1M | $75.5M | ||
| Q1 24 | $1.3M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $9.8M | $93.3M | ||
| Q1 25 | $15.9M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $-1.0M | $54.7M | ||
| Q2 24 | $7.6M | $57.5M | ||
| Q1 24 | $789.0K | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 5.7% | 29.4% | ||
| Q1 25 | 9.7% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | -0.8% | 18.9% | ||
| Q2 24 | 4.7% | 18.8% | ||
| Q1 24 | 0.6% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.2% | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | 5.0% | 3.2% | ||
| Q2 24 | 1.5% | 5.9% | ||
| Q1 24 | 0.4% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.67× | — | ||
| Q1 25 | 3.88× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTM
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
